Exchange: NASDAQ·Updated 07:55 PM EDT
News
all
press releases
HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
Key PointsThe executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100...
Nasdaq News: Markets
More News
Why Heartflow Stock Soared Today
Key PointsHeartflow's AI-powered platform could save countless lives...
Nasdaq News: Markets
HeartFlow Shares Soar Following Strong Q2 Results and Upgraded Guidance
HeartFlow shares are surging Friday after it reported better-than-expected Q2 adjusted EPS results and raised its full-year outlook.read more...
Benzinga
Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On Friday
U.S. stocks up, Dow Jones 0.1% higher. HeartFlow (HTFL) shares rise 26.5% on better-than-expected earnings. Other big gains include ETON, VALN, IMXI.read more...
Benzinga
HeartFlow Q2 2026 Earnings Call Transcript
HeartFlow (NASDAQ:HTFL) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This transcript is brought to you by Benzinga APIs. For real-time access toread more...
Benzinga
HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates
HeartFlow (HTFL) delivered earnings and revenue surprises of +50.00% and +12.96%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of -66.67% and -19.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Doximity (DOCS) Q1 Earnings Lag Estimates
Doximity (DOCS) delivered earnings and revenue surprises of -3.33% and +3.24%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Pulmonx Corporation (LUNG) Reports Q2 Loss, Beats Revenue Estimates
Pulmonx (LUNG) delivered earnings and revenue surprises of +14.29% and +2.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?
Key PointsCEO John Farquhar disposed of 22,562 shares at a transaction value of ~$626,100 on July 10, 2026...
Nasdaq News: Markets

Advertisement|Remove ads.